


EverImmune launches phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer

Keranova’s FemtoMatrix technology produces unprecedented results in clinical regulatory trials

Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials

Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

Ribonexus appoints Steven Powell as CEO

PDC*line Pharma presents first immunological results from phase I/II trial with PDC*lung01 at ESMO-IO 2022

Quest for health accelerator launches in French Grand Est region with focus on healthcare start-ups

BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts
